NORTH AMERICA MEDICAL ENZYMES MARKET 2022-2028

 

 

TABLE OF CONTENTS   

1.     NORTH AMERICA MEDICAL ENZYMES MARKET - SUMMARY

2.     INDUSTRY OUTLOOK

2.1. IMPACT OF COVID-19 ON THE MEDICAL ENZYMES MARKET

2.2. KEY INSIGHTS

2.2.1.    ADVANCEMENTS IN ENZYME ENGINEERING

2.2.2.    INCREASED DEMAND IN THE PHARMACEUTICAL SECTOR

2.3. PORTER’S FIVE FORCES ANALYSIS

2.3.1.    THREAT OF NEW ENTRANTS

2.3.2.    THREAT OF SUBSTITUTES

2.3.3.    BARGAINING POWER OF BUYERS

2.3.4.    BARGAINING POWER OF SUPPLIERS

2.3.5.    THREAT OF COMPETITIVE RIVALRY

2.4. KEY IMPACT ANALYSIS

2.4.1.    PRICE

2.4.2.    QUALITY

2.4.3.    USAGE

2.5. MARKET ATTRACTIVENESS INDEX

2.6. VENDOR SCORECARD

2.7. INDUSTRY COMPONENTS

2.7.1.    RESEARCH AND DEVELOPMENT

2.7.2.    OPERATIONS

2.7.3.    OUTBOUND LOGISTICS

2.8. REGULATORY FRAMEWORK

2.9. KEY MARKET STRATEGIES

2.9.1.    MERGERS & ACQUISITIONS

2.9.2.    PRODUCT LAUNCHES & DEVELOPMENTS

2.9.3.    PARTNERSHIPS & AGREEMENTS

2.9.4.    BUSINESS EXPANSIONS & DIVESTITURES

2.10.               MARKET DRIVERS

2.10.1.                    RISING INVESTMENTS IN RESEARCH AND DEVELOPMENT

2.10.2.                    RISING AGING POPULATION AND OCCURRENCE OF CHRONIC DISEASES

2.10.3.                    INCREASING APPLICATIONS IN THE PHARMACEUTICAL INDUSTRY

2.11.               MARKET CHALLENGES

2.11.1.                    STRICT REGULATIONS

2.11.2.                    SAFETY CONCERNS WHILE HANDLING ENZYMES

2.12.               MARKET OPPORTUNITIES

2.12.1.                    RISING HEALTH ISSUES AND GROWING AWARENESS

2.12.2.                    RISING DEMAND FOR SPECIALTY ENZYMES

3.     NORTH AMERICA MEDICAL ENZYMES MARKET OUTLOOK - BY PRODUCT TYPE

3.1. HYDROLASE

3.1.1.    HYALURONIDASE

3.1.2.    LYSOZYMES

3.1.3.    OTHER HYDROLASES ENZYMES

3.2. THROMBOLYTIC ENZYME

3.2.1.    STREPTOKINASE

3.2.2.    UROKINASE

3.2.3.    OTHER THROMBOLYTIC ENZYMES

3.3. DIGESTIVE ENZYME

3.3.1.    LACTASE

3.3.2.    L-ASPARAGINASE

3.3.3.    OTHER DIGESTIVE ENZYMES

3.4. ENDONUCLEASE

3.4.1.    BENZONASE

3.4.2.    OTHER ENDONUCLEASES

4.     NORTH AMERICA MEDICAL ENZYMES MARKET OUTLOOK - BY APPLICATION

4.1. DISEASE TREATMENT

4.2. DIAGNOSTIC TOOLS

4.3. BIOMEDICAL RESEARCH

4.4. OTHER APPLICATIONS

5.     NORTH AMERICA MEDICAL ENZYMES MARKET – COUNTRY OUTLOOK

5.1. UNITED STATES

5.2. CANADA

6.     COMPETITIVE LANDSCAPE

6.1. BASF SE

6.2. DUPONT

6.3. ROCHE HOLDING AG

6.4. NOVOZYMES

6.5. DSM

6.6. SANOFI SA

6.7. CODEXIS

6.8. ADVANCED ENZYMES

6.9. AMANO ENZYME

6.10.               BBI SOLUTIONS

6.11.               THERMOFISHER SCIENTIFIC INC

6.12.               CPC BIOTECH

6.13.               NOVUS

6.14.               BRAIN BIOTECH AG

6.15.               SEKISUI

7.     RESEARCH METHODOLOGY & SCOPE

7.1. RESEARCH SCOPE & DELIVERABLES

7.2. SOURCES OF DATA

7.3. RESEARCH METHODOLOGY

 

 LIST OF TABLES

TABLE 1: NORTH AMERICA MEDICAL ENZYMES MARKET, BY COUNTRY, 2022-2028 (IN $ MILLION)

TABLE 2: APPLICATIONS OF ENZYMES IN THE PHARMACEUTICALS INDUSTRY

TABLE 3: VENDOR SCORECARD

TABLE 4: REGULATORY FRAMEWORK

TABLE 5: LIST OF MERGERS & ACQUISITIONS

TABLE 6: LIST OF PRODUCT LAUNCHES & DEVELOPMENTS

TABLE 7: LIST OF PARTNERSHIPS & AGREEMENTS

TABLE 8: LIST OF BUSINESS EXPANSIONS & DIVESTITURES

TABLE 9: MEDICAL APPLICATION OF VARIOUS ENZYMES

TABLE 10: NORTH AMERICA MEDICAL ENZYMES MARKET, BY PRODUCT TYPE, 2022-2028 (IN $ MILLION)

TABLE 11: NORTH AMERICA MEDICAL ENZYMES MARKET, BY HYDROLASE ENZYME, 2022-2028 (IN $ MILLION)

TABLE 12: NORTH AMERICA MEDICAL ENZYMES MARKET, BY THROMBOLYTIC ENZYME, 2022-2028 (IN $ MILLION)

TABLE 13: NORTH AMERICA MEDICAL ENZYMES MARKET, BY DIGESTIVE ENZYME, 2022-2028 (IN $ MILLION)

TABLE 14: NORTH AMERICA MEDICAL ENZYMES MARKET, BY ENDONUCLEASE, 2022-2028 (IN $ MILLION)

TABLE 15: NORTH AMERICA MEDICAL ENZYMES MARKET, BY APPLICATION, 2022-2028 (IN $ MILLION)

TABLE 16: NORTH AMERICA MEDICAL ENZYMES MARKET, BY COUNTRY, 2022-2028 (IN $ MILLION)

 

LIST OF FIGURES

FIGURE 1: KEY BUYING IMPACT ANALYSIS

FIGURE 2: MARKET ATTRACTIVENESS INDEX

FIGURE 3: INDUSTRY COMPONENTS

FIGURE 4: NORTH AMERICA MEDICAL ENZYMES MARKET, BY PRODUCT TYPE, 2021 & 2028 (IN %)

FIGURE 5: NORTH AMERICA MEDICAL ENZYMES MARKET, BY HYDROLASE, 2022-2028 (IN $ MILLION)

FIGURE 6: NORTH AMERICA MEDICAL ENZYMES MARKET, BY HYDROLASE ENZYME, 2021 & 2028 (IN %)

FIGURE 7: NORTH AMERICA MEDICAL ENZYMES MARKET, BY HYALURONIDASE, 2022-2028 (IN $ MILLION)

FIGURE 8: NORTH AMERICA MEDICAL ENZYMES MARKET, BY LYSOZYMES, 2022-2028 (IN $ MILLION)

FIGURE 9: NORTH AMERICA MEDICAL ENZYMES MARKET, BY OTHER HYDROLASES ENZYMES, 2022-2028 (IN $ MILLION)

FIGURE 10: NORTH AMERICA MEDICAL ENZYMES MARKET, BY THROMBOLYTIC ENZYME, 2022-2028 (IN $ MILLION)

FIGURE 11: NORTH AMERICA MEDICAL ENZYMES MARKET, BY THROMBOLYTIC ENZYME, 2021 & 2028 (IN %)

FIGURE 12: NORTH AMERICA MEDICAL ENZYMES MARKET, BY STREPTOKINASE, 2022-2028 (IN $ MILLION)

FIGURE 13: NORTH AMERICA MEDICAL ENZYMES MARKET, BY UROKINASE, 2022-2028 (IN $ MILLION)

FIGURE 14: NORTH AMERICA MEDICAL ENZYMES MARKET, BY OTHER THROMBOLYTIC ENZYMES, 2022-2028 (IN $ MILLION)

FIGURE 15: NORTH AMERICA MEDICAL ENZYMES MARKET, BY DIGESTIVE ENZYME, 2022-2028 (IN $ MILLION)

FIGURE 16: NORTH AMERICA MEDICAL ENZYMES MARKET, BY DIGESTIVE ENZYME, 2021 & 2028 (IN %)

FIGURE 17: NORTH AMERICA MEDICAL ENZYMES MARKET, BY LACTASE, 2022-2028 (IN $ MILLION)

FIGURE 18: NORTH AMERICA MEDICAL ENZYMES MARKET, BY L-ASPARAGINASE, 2022-2028 (IN $ MILLION)

FIGURE 19: NORTH AMERICA MEDICAL ENZYMES MARKET, BY OTHER DIGESTIVE ENZYMES, 2022-2028 (IN $ MILLION)

FIGURE 20: NORTH AMERICA MEDICAL ENZYMES MARKET, BY ENDONUCLEASE, 2022-2028 (IN $ MILLION)

FIGURE 21: NORTH AMERICA MEDICAL ENZYMES MARKET, BY ENDNUCLEASE ENZYME, 2021 & 2028 (IN %)

FIGURE 22: NORTH AMERICA MEDICAL ENZYMES MARKET, BY BENZONASE, 2022-2028 (IN $ MILLION)

FIGURE 23: NORTH AMERICA MEDICAL ENZYMES MARKET, BY OTHER ENDONUCLEASES, 2022-2028 (IN $ MILLION)

FIGURE 24: NORTH AMERICA MEDICAL ENZYMES MARKET, BY APPLICATION, 2021 & 2028 (IN %)

FIGURE 25: NORTH AMERICA MEDICAL ENZYMES MARKET, BY DISEASE TREATMENT, 2022-2028 (IN $ MILLION)

FIGURE 26: NORTH AMERICA MEDICAL ENZYMES MARKET, BY DIAGNOSTIC TOOLS, 2022-2028 (IN $ MILLION)

FIGURE 27: NORTH AMERICA MEDICAL ENZYMES MARKET, BY BIOMEDICAL RESEARCH, 2022-2028 (IN $ MILLION)

FIGURE 28: NORTH AMERICA MEDICAL ENZYMES MARKET, BY OTHER APPLICATIONS, 2022-2028 (IN $ MILLION)

FIGURE 29: NORTH AMERICA MEDICAL ENZYMES MARKET, COUNTRY OUTLOOK, 2021 & 2028 (IN %)

FIGURE 30: UNITED STATES MEDICAL ENZYMES MARKET 2022-2028 (IN $ MILLION)

FIGURE 31: CANADA MEDICAL ENZYMES MARKET 2022-2028 (IN $ MILLION)

 

Increased demand for medical enzymes for disease treatment is driving the market growth

 

MARKET OUTLOOK

According to Triton Market Research, the North America medical enzymes market is anticipated to develop with a CAGR of 6.57% in the estimated period from 2022 to 2028. The United States and Canada are evaluated in the market in this region.

Cardiovascular disease and cancer are the two leading causes of mortality in Canada, according to a WHO report. A survey by the Canadian Cancer Society had predicted that 118,200 males in Canada would receive cancer diagnoses in 2021, of whom 44,600 were likely to die. As a result, it is anticipated that there would be a strong demand for therapeutic medicinal enzymes used to treat these disorders. This would, in turn, consolidate the medical enzymes market in Canada.

The market in the United States is expected to expand as a result of the market players’ presence in the nation, their partnerships or collaborations, and the introduction of new products by them. For instance, for the treatment of gastrointestinal illnesses, Codexis and Nestle Health Science collaborated on a project for the development of novel enzyme therapies.

Moreover, Codexis also extended its partnership deal with Tate and Lyle, a major provider of food & beverage ingredients, which will aid in the expansion of the company. The company also launched reverse transcriptase to be utilized in one-step reverse transcription, and other similar product launches. Whereas, DuPont introduced Enovera 3001, an enzyme-only solution. Such developments are anticipated to foster market expansion.

 

Get more insights into the North America Medical Enzymes Market:

 

https://www.tritonmarketresearch.com/reports/north-america-medical-enzymes-market

 

COMPETITIVE OUTLOOK

Novus, BBI Solutions, DuPont, Novozymes, Roche Holding AG, Sanofi SA, Thermofisher Scientific Inc, and Brain Biotech AG are some of the noteworthy companies in the medical enzymes market.

 

SEGMENTATION

1.     BASF SE

2.     DUPONT

3.     ROCHE HOLDING AG

4.     NOVOZYMES

5.     DSM

6.     SANOFI SA

7.     CODEXIS

8.     ADVANCED ENZYMES

9.     AMANO ENZYME

10. BBI SOLUTIONS

11. THERMOFISHER SCIENTIFIC INC

12. CPC BIOTECH

13. NOVUS

14. BRAIN BIOTECH AG

15. SEKISUI